Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 71 checked references that resolve
resolves10.1038/s41531-018-0060-6Loss of glutamate signaling from the thalamus to dorsal striatum impairs motor function and slows the execution of learned behaviors
resolves10.1523/JNEUROSCI.0014-13.2013Acetylcholine Encodes Long-Lasting Presynaptic Plasticity at Glutamatergic Synapses in the Dorsal Striatum after Repeated Amphetamine Exposure
resolves10.1073/pnas.1006511108Enhanced striatal cholinergic neuronal activity mediates
<scp>l</scp>
-DOPA–induced dyskinesia in parkinsonian mice
resolves10.1016/j.neuron.2008.01.033Repeated Exposure to Methamphetamine Causes Long-Lasting Presynaptic Corticostriatal Depression that Is Renormalized with Drug Readministration
resolves10.1073/pnas.1101424108Balanced NMDA receptor activity in dopamine D1 receptor (D1R)- and D2R-expressing medium spiny neurons is required for amphetamine sensitization
resolves10.1037/h0058775Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain.
resolves10.1021/ac5026072Characterization of Solute Distribution Following Iontophoresis from a Micropipet
resolves10.1038/372770a0A thalamic nucleus specific for pain and temperature sensation
resolves10.1016/j.jaac.2017.04.005Striatal Activation Predicts Differential Therapeutic Responses to Methylphenidate and Atomoxetine
resolves10.1152/jn.1998.79.4.1768Modulation of Synaptic Transmission by Dopamine and Norepinephrine in Ventral but not Dorsal Striatum
resolves10.1136/jnnp.2009.185348A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome
resolves10.1212/WNL.0000000000007466Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders
resolves10.1016/j.clinthera.2008.01.010Donepezil use in children and adolescents with tics and attention-deficit/hyperactivity disorder: An 18-week, single-center, dose-escalating, prospective, open-label study
resolves10.1007/s40474-015-0063-5Behavior Therapy for Tic Disorders: an Evidenced-Based Review and New Directions for Treatment Research
resolves10.1016/j.brat.2009.07.021Cognitive behavioral management of Tourette's syndrome and chronic tic disorder in medicated and unmedicated samples
resolves10.1016/j.jad.2012.01.022Localization of cerebral functional deficits in patients with obsessive–compulsive disorder: A resting-state fMRI study
resolves10.1016/j.psc.2009.05.004The Neurobiology of Anxiety Disorders: Brain Imaging, Genetics, and Psychoneuroendocrinology
resolves10.1159/000337776Deep Brain Stimulation for Tourette Syndrome: Target Selection
resolves10.3390/brainsci7120161The Role of Transcranial Direct Current Stimulation (tDCS) in Tourette Syndrome: A Review and Preliminary Findings
resolves10.3390/brainsci8070129Transcranial Magnetic Stimulation in Tourette Syndrome: A Historical Perspective, Its Current Use and the Influence of Comorbidities in Treatment Response
resolves10.1002/mds.27705The use of transcranial magnetic stimulation as a treatment for movement disorders: A critical review
resolves10.1111/ner.12372Computer-Guided Deep Brain Stimulation Programming for Parkinson’s Disease
resolves10.1016/j.jocn.2012.01.049Transcranial magnetic stimulation at 1Hertz improves clinical symptoms in children with Tourette syndrome for at least 6 months
resolves10.1073/pnas.1501364112Protein mutated in paroxysmal dyskinesia interacts with the active zone protein RIM and suppresses synaptic vesicle exocytosis
resolves10.1056/NEJM199109053251006Defective Glucose Transport across the Blood-Brain Barrier as a Cause of Persistent Hypoglycorrhachia, Seizures, and Developmental Delay
resolves10.1056/NEJMoa1815408Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1
resolves10.1002/mds.25382Levodopa‐induced dyskinesias in tyrosine hydroxylase deficiency
resolves10.1093/brain/awx189Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology
resolves10.1093/brain/aws256Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders
resolves10.1007/s00234-003-0999-8Clinical, laboratory, psychiatric and magnetic resonance findings in patients with Sydenham chorea
resolves10.5334/tohm.376Treatment of Sydenham’s Chorea: A Review of the Current Evidence
resolves10.1080/08916930500484757Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham's chorea
resolves10.1176/ajp.155.2.264Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections: Clinical Description of the First 50 Cases
resolves10.1016/j.jaac.2010.10.011Streptococcal Upper Respiratory Tract Infections and Exacerbations of Tic and Obsessive-Compulsive Symptoms: A Prospective Longitudinal Study
resolves10.1016/j.jpeds.2018.04.035A Pediatric Neurology Perspective on Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infection and Pediatric Acute-Onset Neuropsychiatric Syndrome
resolves10.1136/jnnp-2015-311803Differences in globus pallidus neuronal firing rates and patterns relate to different disease biology in children with dystonia
checked 2026-07-22 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.